Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Non-Current Assets: 2024-2025

Historic Non-Current Assets for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $28.7 million.

  • Kura Oncology's Non-Current Assets rose 83.53% to $28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 83.53%. This contributed to the annual value of $15.3 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Non-Current Assets of $28.7 million as of Q3 2025, which was up 28.49% from $22.4 million recorded in Q2 2025.
  • Over the past 5 years, Kura Oncology's Non-Current Assets peaked at $28.7 million during Q3 2025, and registered a low of $15.3 million during Q4 2024.